Harbin Pharma Surges: Three‑Board Rally Signals Resurgent Investor Confidence
Harbin Pharmaceutical’s three‑board surge shows rising investor confidence in China’s pharma sector—yet highlights risks of high valuation and thin margins.
3 minutes to read